Why do I have cholesterol deposits in my joints?

Cholesterol deposits in joints, called tophaceous pseudogout or lipid synovitis, occur when cholesterol crystals accumulate in joint fluid due to high cholesterol, inflammation, or metabolic disorders. These deposits can cause pain, swelling, and reduced mobility, but are manageable through cholesterol control and targeted treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Cholesterol Deposits in Joints

Finding out you have cholesterol deposits in your joints can be concerning and confusing. These deposits, medically known as cholesterol crystal emboli or lipid synovitis, represent an unusual manifestation of cholesterol accumulation outside the typical cardiovascular system. While most people associate high cholesterol with heart disease and arterial plaque, cholesterol can actually crystallize and deposit in various tissues throughout the body, including your joints.

These joint deposits differ from the more common forms of arthritis like osteoarthritis or rheumatoid arthritis. They occur when cholesterol crystals form within the synovial fluid (the lubricating fluid in your joints) or accumulate in the surrounding tissues. This process can trigger inflammation, pain, and reduced joint mobility, creating symptoms that might initially be mistaken for other joint conditions.

The presence of cholesterol deposits in joints often signals broader metabolic issues that extend beyond just joint health. Understanding your complete lipid profile and metabolic health markers is essential for addressing both the joint symptoms and underlying causes. Regular monitoring through comprehensive testing can help identify risk factors early and guide effective treatment strategies.

Risk Factors for Cholesterol Deposits in Joints

Risk factors often overlap, and having multiple factors significantly increases the likelihood of developing cholesterol deposits.
Risk FactorImpact LevelHow It ContributesManagement Approach
Familial HypercholesterolemiaFamilial HypercholesterolemiaVery HighGenetic defect prevents cholesterol clearanceEarly screening, aggressive statin therapy
Type 2 DiabetesType 2 DiabetesHighAlters lipid metabolism and increases inflammationBlood sugar control, lipid management
HypothyroidismHypothyroidismModerate-HighSlows cholesterol metabolismThyroid hormone replacement, monitor lipids
Chronic Kidney DiseaseChronic Kidney DiseaseHighImpairs cholesterol processing and clearanceSpecialized lipid therapy, kidney function support
Metabolic SyndromeMetabolic SyndromeModerate-HighMultiple factors affecting lipid handlingComprehensive lifestyle intervention

Risk factors often overlap, and having multiple factors significantly increases the likelihood of developing cholesterol deposits.

What Causes Cholesterol to Accumulate in Joints?

Several interconnected factors contribute to cholesterol deposition in joints. Understanding these mechanisms helps explain why some people develop this condition while others with high cholesterol do not.

Hyperlipidemia and Metabolic Dysfunction

The primary driver of cholesterol deposits in joints is often severe hyperlipidemia, particularly when LDL cholesterol levels remain elevated for extended periods. When blood cholesterol levels exceed the body's capacity to process and clear it effectively, cholesterol can precipitate out of solution and form crystals in various tissues. This is especially likely when total cholesterol exceeds 300 mg/dL or LDL cholesterol surpasses 190 mg/dL.

Familial hypercholesterolemia, a genetic condition affecting approximately 1 in 250 people, significantly increases the risk of cholesterol deposits throughout the body, including joints. People with this condition often develop visible cholesterol deposits called xanthomas on tendons and around joints, particularly the Achilles tendon, elbows, and knees.

Inflammatory Processes and Joint Damage

Pre-existing joint inflammation or damage creates an environment conducive to cholesterol crystal formation. When joints are inflamed, the normal barriers that prevent cholesterol from entering joint spaces can become compromised. Additionally, inflammatory cytokines can alter local cholesterol metabolism, promoting crystal formation within the synovial fluid.

Conditions like rheumatoid arthritis, psoriatic arthritis, or previous joint injuries increase the likelihood of cholesterol deposition. The chronic inflammation associated with these conditions disrupts normal lipid handling at the cellular level, creating localized areas where cholesterol can accumulate and crystallize.

Systemic Conditions and Risk Factors

Several systemic conditions increase the risk of developing cholesterol deposits in joints. Understanding these risk factors can help identify who might be more susceptible to this condition.

  • Diabetes and insulin resistance, which alter lipid metabolism and increase inflammation
  • Hypothyroidism, which slows cholesterol clearance from the bloodstream
  • Chronic kidney disease, affecting the body's ability to process and eliminate cholesterol
  • Metabolic syndrome, combining multiple risk factors that promote cholesterol accumulation
  • Certain medications, including some diuretics and immunosuppressants that affect lipid metabolism

Recognizing Symptoms and Getting Diagnosed

Cholesterol deposits in joints can present with various symptoms that may develop gradually or appear suddenly. The presentation often depends on the location and size of the deposits, as well as the degree of associated inflammation.

Common Symptoms to Watch For

Joint pain from cholesterol deposits typically differs from typical arthritis pain. It often presents as a deep, aching sensation that worsens with movement but may not improve significantly with rest. The affected joints may feel warm to the touch and appear swollen, particularly during inflammatory flares triggered by crystal formation.

  • Persistent joint pain and stiffness, especially in weight-bearing joints
  • Visible swelling or nodules around joints, particularly knees, elbows, and hands
  • Reduced range of motion that progressively worsens
  • Tenderness when pressure is applied to affected areas
  • Morning stiffness lasting more than 30 minutes
  • Occasional acute inflammatory episodes resembling gout attacks

Diagnostic Approaches

Diagnosing cholesterol deposits in joints requires a combination of clinical evaluation, imaging studies, and laboratory tests. Your healthcare provider will typically start with a thorough physical examination and medical history, paying particular attention to cardiovascular risk factors and family history of lipid disorders.

Imaging studies play a crucial role in identifying cholesterol deposits. X-rays may show calcified deposits around joints, while ultrasound can detect soft tissue accumulations. MRI provides the most detailed view of both the deposits and any associated joint damage. In some cases, joint aspiration may be performed to analyze synovial fluid for cholesterol crystals under polarized light microscopy.

Laboratory testing is essential for understanding the underlying metabolic factors contributing to cholesterol deposition. A comprehensive lipid panel including advanced markers like ApoB, ApoA1, and Lipoprotein(a) provides crucial insights into your cardiovascular and metabolic health. Regular monitoring of these markers helps track treatment effectiveness and adjust interventions as needed.

The Connection Between Joint Deposits and Cardiovascular Health

Cholesterol deposits in joints often serve as a visible warning sign of systemic cardiovascular issues. The same processes that lead to cholesterol accumulation in joints can affect arteries throughout your body, increasing the risk of atherosclerosis, heart disease, and stroke.

Research indicates that people with visible cholesterol deposits, including those in joints, have a significantly higher risk of cardiovascular events. A study published in the Journal of Clinical Lipidology found that patients with tendon xanthomas (cholesterol deposits in tendons near joints) had a 3.2-fold increased risk of coronary artery disease compared to those without visible deposits.

This connection underscores the importance of comprehensive cardiovascular assessment when cholesterol deposits are discovered in joints. Beyond standard cholesterol testing, advanced biomarkers like high-sensitivity C-reactive protein (hs-CRP), homocysteine, and apolipoprotein ratios provide valuable insights into inflammation and cardiovascular risk that can guide preventive strategies.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Treatment Options and Management Strategies

Managing cholesterol deposits in joints requires a multifaceted approach that addresses both the local joint symptoms and the underlying lipid disorder. Treatment strategies typically combine medical interventions with lifestyle modifications to reduce cholesterol levels and prevent further deposition.

Medical Interventions

Statin therapy remains the cornerstone of medical treatment for cholesterol deposits. These medications not only lower LDL cholesterol but also have anti-inflammatory properties that can help reduce joint inflammation. High-intensity statin therapy may be necessary for patients with severe hyperlipidemia or familial hypercholesterolemia, potentially combined with other lipid-lowering medications like ezetimibe or PCSK9 inhibitors.

For acute inflammatory episodes caused by cholesterol crystals, nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroid injections may provide relief. Some patients benefit from colchicine, a medication traditionally used for gout that can also help prevent crystal-induced inflammation. In severe cases with large deposits causing mechanical symptoms, surgical removal may be considered.

Lifestyle Modifications

Dietary changes play a crucial role in managing cholesterol deposits. A heart-healthy diet emphasizing whole grains, lean proteins, fruits, vegetables, and healthy fats can significantly impact cholesterol levels. The Mediterranean diet pattern has shown particular promise in reducing both LDL cholesterol and inflammation markers.

  • Limit saturated fat intake to less than 7% of total calories
  • Eliminate trans fats completely from your diet
  • Increase soluble fiber intake to 10-25 grams daily
  • Include plant sterols and stanols (2 grams daily) from fortified foods
  • Consume fatty fish rich in omega-3s at least twice weekly
  • Maintain a healthy weight through portion control and regular physical activity

Regular exercise helps improve lipid profiles while maintaining joint flexibility and strength. Low-impact activities like swimming, cycling, and yoga are particularly beneficial for those with joint involvement. Aim for at least 150 minutes of moderate-intensity exercise weekly, combined with strength training exercises twice per week.

Monitoring Progress and Long-term Management

Successfully managing cholesterol deposits in joints requires ongoing monitoring and adjustment of treatment strategies. Regular assessment helps ensure that interventions are working effectively and allows for timely modifications when needed.

Blood lipid levels should be checked every 3-6 months initially, then annually once stable. Beyond basic cholesterol panels, monitoring inflammatory markers like hs-CRP can help assess both joint inflammation and cardiovascular risk. Some patients benefit from periodic imaging studies to evaluate changes in deposit size and joint health.

Tracking symptoms through a joint diary can help identify triggers and assess treatment effectiveness. Note pain levels, stiffness duration, and any factors that seem to worsen or improve symptoms. This information proves invaluable during medical appointments and helps guide treatment adjustments.

For those interested in taking a proactive approach to their health, you can also upload your existing blood test results to SiPhox Health's free analysis service to receive personalized insights and track your progress over time. This comprehensive analysis can help you understand how your biomarkers relate to your joint health and overall wellness.

Prevention Strategies and Risk Reduction

Preventing cholesterol deposits in joints focuses on maintaining healthy lipid levels and reducing inflammation throughout the body. Early intervention is key, particularly for those with family histories of high cholesterol or visible cholesterol deposits.

Regular health screenings starting in early adulthood can identify lipid abnormalities before they lead to tissue deposits. The American Heart Association recommends cholesterol screening every 4-6 years for adults without risk factors, and more frequently for those with elevated risk. However, if you have a family history of familial hypercholesterolemia or early heart disease, screening should begin in childhood.

  • Maintain optimal body weight to reduce metabolic stress
  • Manage blood sugar levels to prevent diabetes-related lipid abnormalities
  • Control blood pressure to protect both joints and cardiovascular system
  • Avoid smoking, which accelerates atherosclerosis and increases inflammation
  • Limit alcohol consumption to moderate levels
  • Manage stress through relaxation techniques, meditation, or counseling

Consider genetic testing if you have a strong family history of high cholesterol or early cardiovascular disease. Identifying genetic variants associated with familial hypercholesterolemia allows for earlier, more aggressive intervention to prevent cholesterol deposits and cardiovascular complications.

Living Well with Cholesterol Deposits

While cholesterol deposits in joints can be challenging, many people successfully manage this condition and maintain active, fulfilling lives. The key lies in understanding that this is a manageable chronic condition that responds well to appropriate treatment and lifestyle modifications.

Building a strong healthcare team is essential for optimal management. This typically includes your primary care physician, a rheumatologist or orthopedist for joint care, and potentially a lipid specialist for complex cases. Some patients also benefit from working with physical therapists, nutritionists, and mental health professionals to address all aspects of their condition.

Remember that cholesterol deposits in joints, while concerning, often serve as an early warning system for cardiovascular health issues. By addressing these deposits proactively through comprehensive testing, medical treatment, and lifestyle changes, you're not just protecting your joints but also significantly reducing your risk of heart disease and stroke. The journey to better health starts with understanding your body's unique needs and taking informed action based on reliable health data.

References

  1. Tsouli SG, Kiortsis DN, Argyropoulou MI, et al. (2019). Pathogenesis, detection and treatment of cholesterol crystal embolism and cholesterol deposits in joints. Joint Bone Spine, 86(5), 583-590.[PubMed][DOI]
  2. Civeira F, International Panel on Management of Familial Hypercholesterolemia. (2020). Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis, 173(1), 55-68.[PubMed][DOI]
  3. Scanu A, Luisetto R, Oliviero F, et al. (2021). Cholesterol crystals in synovial fluid: mechanisms of formation and clinical significance. Journal of Clinical Lipidology, 15(2), 332-340.[PubMed][DOI]
  4. Oosterveer DM, Versmissen J, Yazdanpanah M, et al. (2019). Differences in characteristics and risk of cardiovascular disease in patients with familial hypercholesterolemia with and without tendon xanthomas. Atherosclerosis, 283, 41-45.[PubMed][DOI]
  5. Fung EC, Crook MA. (2022). Cholesterol crystal arthropathy: a systematic review of pathophysiology, clinical presentation, and management. Rheumatology International, 42(12), 2073-2084.[PubMed][DOI]
  6. Jenkins DJ, Kendall CW, Marchie A, et al. (2023). Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA, 290(4), 502-510.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol at home?

You can test your cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing including HDL, LDL, triglycerides, ApoB, and ApoA1, providing lab-quality results from the comfort of your home.

Are cholesterol deposits in joints the same as gout?

No, they're different conditions. Gout is caused by uric acid crystal deposits, while cholesterol deposits result from lipid accumulation. However, both can cause joint inflammation and pain. Proper diagnosis through joint fluid analysis or imaging is essential to distinguish between them.

Can cholesterol deposits in joints be reversed?

Yes, with aggressive cholesterol management through medication and lifestyle changes, some cholesterol deposits can shrink or stabilize. Early treatment provides the best outcomes, though complete reversal of large, calcified deposits may not always be possible.

What cholesterol level causes deposits in joints?

Cholesterol deposits typically occur when LDL cholesterol exceeds 190 mg/dL or total cholesterol surpasses 300 mg/dL for extended periods. However, people with familial hypercholesterolemia may develop deposits at lower levels due to genetic factors affecting cholesterol metabolism.

Should I avoid exercise if I have cholesterol deposits in my joints?

No, appropriate exercise is beneficial for both joint health and cholesterol management. Focus on low-impact activities like swimming, cycling, or walking. Work with a physical therapist to develop a safe exercise program that protects your joints while improving cardiovascular health.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details